Patents by Inventor Annette Lauridsen

Annette Lauridsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Benzimidazol-2-one derivatives and their use
    Patent number: 7244756
    Abstract: Certain 1,5-disubstituted benzimidazol-2-one compounds useful as therapeutic agents. The compounds may be of the Formula I wherein: R? represents hydrogen or alkyl; R? represents halogen or trihalogenmethyl; and Hlg represents halogen; provided, however, that if Hlg is F, then R? is not Cl. Also, use of the 1,5-disubstituted benzimidazol-2-one compounds, or pharmaceutically-acceptable addition salts thereof, in applications that benefit from increasing the blood-brain barrier permeability.
    Type: Grant
    Filed: June 17, 2003
    Date of Patent: July 17, 2007
    Assignee: Poseidon Pharmaceuticals A/S
    Inventors: Lars Siim Madsen, Camilla ærteberg Bæk, Annette Lauridsen, Søren Peter Olesen
  • Novel benzimidazol-2-one derivatives and their use
    Publication number: 20050250832
    Abstract: The present invention provides novel benzimidazol-2-one derivatives useful as therapeutic agents.
    Type: Application
    Filed: June 17, 2003
    Publication date: November 10, 2005
    Inventors: Lars Madsen, Camilla Baek, Annette Lauridsen, Soren Olesen